Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc., trading under ticker ARYB, is a life sciences SPAC vehicle that filed an 8-K with the SEC on July 30, 2020, tied to accession number 0001140361-20-017009. The vehicle is associated with the ARYA Sciences Acquisition Corp II structure, sponsored by Perceptive Advisors, a healthcare-focused investment firm with a track record in life sciences blank-check vehicles. The SPAC IPO'd in 2020 with a focus on the biopharmaceutical and neuroscience sector, targeting companies developing treatments for central nervous system disorders. Cerevel Therapeutics itself operates in CNS drug discovery and development. For complete filing history, sponsor details, and deal analytics on ARYB and comparable life sciences SPACs, sign up for full data access at SpacDesk.